Immunovant (IMVT) Notes Payables (2018 - 2019)
Immunovant (IMVT) posted Notes Payables of $300000.0 for Q1 2019, little changed on a QoQ basis from $300000.0 in Q4 2018.
Immunovant (IMVT) Notes Payables (2018 - 2019) Analysis & Trends
Immunovant's Notes Payables history runs 2 years deep, the most recent figure standing at $300000.0 for Q1 2019.
- Quarterly Notes Payables changed N/A year-over-year to $300000.0 in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $300000.0 (changed N/A YoY) and the FY2019 annual result came in at $300000.0, changed N/A from the prior year.
- Notes Payables was $300000.0 for Q1 2019 at Immunovant, roughly flat from $300000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $300000.0 in Q4 2018 and bottomed at $300000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 300,000.00 |
| Dec 31, 2018 | 300,000.00 |